Search Thermo Fisher Scientific
UBD qualifies as a marker for an interferon response in hepatocellular carcinoma and colon carcinoma but is not significantly overexpressed in cancers lacking a proinflammatory environment. Immunohistochemical studies demonstrated increased UBD expression in HIV-associated nephropathy and in autosomal dominant polycystic kidney disease.
Diubiquitin; FAT10; GABBR1; Ubd; UBD 3; UBD-3; Ubiquitin D; ubiquitin-like protein FAT10
100 µL
100 µL
100 µL
400 µL
100 µg
100 µg
100 µL
100 µL
100 µL
100 µL
50 µg
100 µg
50 µg
100 µL